ChemoCentryx
CCXI
#3654
Rank
HK$29.33 B
Marketcap
HK$407.90
Share price
0.00%
Change (1 day)
34.95%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.83. In 2021 the company made an earnings per share (EPS) of -HK$14.83 a decrease over its 2020 EPS that were of -HK$6.36.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.78-0.36%
2021-HK$14.83133.33%
2020-HK$6.36-16.49%
2019-HK$7.6127.63%
2018-HK$5.96-305.41%
2017HK$2.90-142.53%
2016-HK$6.83-19.44%
2015-HK$8.47-0%
2014-HK$8.4713.68%
2013-HK$7.45-16.67%
2012-HK$8.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.41-453.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.57-137.57%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$45.91-409.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$136.36-1,019.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
HK$18.52-224.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$7.79-152.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.46-339.15%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$22.57-252.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$3.53-123.81%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel